Document Detail


Management of venous thromboembolism.
MedLine Citation:
PMID:  17444345     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Venous Thromboembolism is an important healthcare problem the world over, resulting in significant morbidity, mortality and resource expenditure. The rationale for use of thromboprophylaxis is based on solid principles and scientific evidence. Indian perspective on this topic is lacking due to the non-availability of published Indian data. This document reviews the available International and Indian data and discusses the relevance of recommendations for prevention and management of Venous Thromboembolism (VTE) in the Indian context. MATERIALS AND METHODS: Meetings of various specialists from different Indian hospitals in the field of Gastrointestinal Surgery, General and Vascular Surgery, Hematology, Intensive Care, Obstetrics and Gynecology, Oncology and Orthopedics were held in the months of August 2005 to January 2006. The guidelines published by American College of Chest Physicians (ACCP), the International Union of Angiology (IUA), and the Royal College of Obstetricians and Gynecologists (RCOG), were discussed during these meetings. The relevance of these guidelines and the practical implications of following these in a developing country like India were also discussed. Any published data from India was collected from data base searches and the results, along with personal experiences of the participating specialists were discussed. The experiences and impressions of the experts during these meetings have been included in this document. Data from recent sources (International Union of Angiology and the National Comprehensive Cancer Network (NCCN) Practice guidelines in Oncology on Venous thromboembolic disease) was subsequently also included in this document. RESULTS: The suggestions formulated in this document are practical, and would intend to serve as a useful practical reference. CONCLUSIONS: A number of unanswered questions remain in the field of thromboprophylaxis, and carefully designed research protocols may help answer some of these. Implementation of the suggestions outlined in the document remains to be studied in the Indian context.
Authors:
R Parakh; V V Kakkar; A K Kakkar;
Related Documents :
15859975 - Impact of introducing guidelines on anticoagulant reversal.
11706885 - Guidelines for arthritis: ten years on.
19565435 - Shoulder dystocia: comparison of the acog practice bulletin with another national guide...
9699135 - The new viral haemorrhagic fever infection control guidelines.
2351895 - A critique of principlism.
22018165 - Objective structured practical examination (ospe) in forensic medicine: students' point...
Publication Detail:
Type:  Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Journal of the Association of Physicians of India     Volume:  55     ISSN:  0004-5772     ISO Abbreviation:  J Assoc Physicians India     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-04-20     Completed Date:  2007-05-08     Revised Date:  2010-03-23    
Medline Journal Info:
Nlm Unique ID:  7505585     Medline TA:  J Assoc Physicians India     Country:  India    
Other Details:
Languages:  eng     Pagination:  49-70     Citation Subset:  IM    
Affiliation:
Dept of Vascular and Indovascular Surgery, Sir Ganga Ram Hospital, Delhi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / adverse effects,  therapeutic use
Humans
Incidence
India / epidemiology
Thromboembolism* / diagnosis,  drug therapy,  epidemiology,  prevention & control
Thrombophilia / etiology
Venous Thrombosis* / diagnosis,  drug therapy,  epidemiology,  prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, ...
Next Document:  Primary duodenal lymphoma producing obstructive jaundice.